Back To Top

Tangs Clinic

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
29
May

Evaluating the economic burden of psoriasis in the United States

Posted by on in Skin Matters
  • Font size: Larger Smaller
  • Hits: 8834
  • 0 Comments
  • Print

The prevalence of psoriasis in the US was estimated to be 7.4 million in 2013. Comparatively,psoriasis patients incurred incremental medical costs of $2284, experienced a $2203 reduction in HRQOL, and a $1935 reduction in productivity. The total burden of psoriasis was estimated as $35.2 billion, with $12.2 billion in incremental medical costs (35%), $11.8 billion from reduced HRQOL (34%), and $11.2 billion from productivity losses (32%).

Evaluating the economic burden of psoriasis in the United States

Reference:

Jacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, etc. (2015) Evaluating the economic burden of psoriasis in the United States. J Am Acad Dermatol 2015;71:961-967

Rate this blog entry:
Trackback URL for this blog entry.

Comments

  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest Saturday, 16 December 2017